Study of novel androgen receptor V770 variant in androgen insensitivity syndrome patients reveals the transitional state of the androgen receptor ligand binding domain homodimer.

MM-GBSA androgen insensitivity syndrome androgen receptor binding free energy decomposition dimerization ligand binding domain mutation

Journal

Protein science : a publication of the Protein Society
ISSN: 1469-896X
Titre abrégé: Protein Sci
Pays: United States
ID NLM: 9211750

Informations de publication

Date de publication:
04 2023
Historique:
revised: 14 02 2023
received: 22 12 2022
accepted: 15 02 2023
pmc-release: 01 04 2024
medline: 3 4 2023
pubmed: 23 2 2023
entrez: 22 2 2023
Statut: ppublish

Résumé

We report the discovery of the androgen receptor missense mutation V770D, that was found in two sisters suffering from complete androgen insensitivity. Experimental validation of AR V770 variants demonstrated that AR V770D was transcriptionally inactive due to the inability to dimerize and a reduced ligand binding affinity. The more conservative AR V770A variant showed a dimerization defect at low levels of DHT with a partial recovery of the transcriptional activity and of the receptor's ability to dimerize when increasing the DHT levels. With V770 located outside of the proposed LBD dimerization interface of the AR LBD homodimer crystal structure, the effects of the V770A mutation on AR dimerization were unexpected. We therefore explored whether the AR LBD dimerization interface would be better described by an alternative dimerization mode based on available human homodimeric LBD crystal structures of other nuclear receptors. Superposition of the monomeric AR LBD in the homodimeric crystal structures of GR, PR, ER, CAR, TRβ, and HNF-4α showed that the GR-like LBD dimer model was energetically the most stable. Moreover, V770 was a key energy residue in the GR-like LBD dimer while it was not involved in the stabilization of the AR LBD homodimer according to the crystal structure. Additionally, the observation that 4 AIS mutations impacted the stability of the AR LBD dimer while 16 mutations affected the GR-like LBD dimer, suggested that the AR LBD dimer crystal is a snapshot of a breathing AR LBD homodimer that can transition into the GR-like LBD dimer model.

Identifiants

pubmed: 36806291
doi: 10.1002/pro.4599
pmc: PMC10019450
doi:

Substances chimiques

Receptors, Androgen 0
Ligands 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e4599

Informations de copyright

© 2023 The Protein Society.

Références

J Comput Chem. 2005 Dec;26(16):1668-88
pubmed: 16200636
Nat Methods. 2015 Apr;12(4):326-8
pubmed: 25730490
Biochim Biophys Acta Gen Subj. 2018 Aug;1862(8):1810-1825
pubmed: 29723544
J Biol Chem. 2022 Feb;298(2):101574
pubmed: 35007536
Mol Endocrinol. 2010 May;24(5):898-913
pubmed: 20304998
Proc Natl Acad Sci U S A. 2004 Apr 6;101(14):4758-63
pubmed: 15037741
Proc Natl Acad Sci U S A. 2007 Oct 9;104(41):16074-9
pubmed: 17911242
EMBO Rep. 2021 Dec 6;22(12):e52764
pubmed: 34661369
Protein Sci. 2023 Apr;32(4):e4599
pubmed: 36806291
Proteins. 2021 Mar 12;:
pubmed: 33713045
PLoS One. 2019 Jan 9;14(1):e0209124
pubmed: 30625138
Nature. 2013 Mar 21;495(7441):394-8
pubmed: 23485969
Proc Natl Acad Sci U S A. 1998 May 26;95(11):5998-6003
pubmed: 9600906
J Mol Biol. 2008 Jan 11;375(2):529-46
pubmed: 18031757
J Comput Chem. 2005 Dec;26(16):1701-18
pubmed: 16211538
Nature. 1998 May 28;393(6683):392-6
pubmed: 9620806
Proteins. 2009 Apr;75(1):111-7
pubmed: 18798561
Cell Mol Life Sci. 2010 Jun;67(11):1919-27
pubmed: 20186458
Mol Cell. 2020 Sep 3;79(5):812-823.e4
pubmed: 32668201
Proteins. 1993 Dec;17(4):412-25
pubmed: 8108382
Nat Clin Pract Urol. 2006 Dec;3(12):653-65
pubmed: 17149382
Mol Cancer Ther. 2022 Dec 2;21(12):1823-1834
pubmed: 36218067
Cell. 2002 Jul 12;110(1):93-105
pubmed: 12151000
Lancet. 2012 Oct 20;380(9851):1419-28
pubmed: 22698698
Nat Commun. 2017 Feb 06;8:14388
pubmed: 28165461
Proteins. 2006 Nov 15;65(3):712-25
pubmed: 16981200
Int J Mol Sci. 2022 Jan 29;23(3):
pubmed: 35163481
Acta Pharmacol Sin. 2015 Jan;36(1):3-23
pubmed: 24909511
Clin Endocrinol (Oxf). 2002 Jan;56(1):1-18
pubmed: 11849240
J Clin Endocrinol Metab. 2022 Nov 17;:
pubmed: 36394509
Mol Cell. 2022 Jun 2;82(11):2021-2031.e5
pubmed: 35447082
Mol Endocrinol. 2008 Nov;22(11):2373-82
pubmed: 18617596

Auteurs

Christine Helsen (C)

Molecular Endocrinology Laboratory, KU Leuven, Leuven, Belgium.

Maria Santa Rocca (MS)

Unit of Andrology and Reproductive Medicine, University Hospital of Padova, Padova, Italy.

Tien T Nguyen (TT)

Laboratory of Biomolecular Modelling and Design, the Chemistry Department, KU Leuven, Heverlee, Belgium.

Roy Eerlings (R)

Molecular Endocrinology Laboratory, KU Leuven, Leuven, Belgium.

Xiao Yin Lee (XY)

Molecular Endocrinology Laboratory, KU Leuven, Leuven, Belgium.

Sofie De Block (S)

Molecular Endocrinology Laboratory, KU Leuven, Leuven, Belgium.

Cinzia Vinanzi (C)

Unit of Andrology and Reproductive Medicine, University Hospital of Padova, Padova, Italy.

Francesco Di Millo (F)

Local Health Authority, Unit of Andrological Prevention, Foggia, Italy.

Vito Giagulli (V)

Santa Maria and Villa Lucia Hospital, GVM Care & Research, Bari, Italy.

Arnout Voet (A)

Laboratory of Biomolecular Modelling and Design, the Chemistry Department, KU Leuven, Heverlee, Belgium.

Alberto Ferlin (A)

Department of Medicine, University of Padova, Padova, Italy.

Frank Claessens (F)

Molecular Endocrinology Laboratory, KU Leuven, Leuven, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH